Halozyme Therapeutics, Inc. (HALO) Dividends

Sorry, we have no dividends for Halozyme Therapeutics, Inc. (HALO) at the moment. :(

HALO

Price: $71.72

52 week price:
51.06
82.22

Payout Ratio Range:
-540.09%
59.91%

Earnings Per Share: 2.85 USD

P/E Ratio: 23.55

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 402302

Ebitda: 127.5 million

Market Capitalization: 8.5 billion

Links: